 | Given the vast amount of misinformation presented in the consumer media regarding cosmetic treatments, In The Know presents patients with information grounded in medicine and coming from the real experts. We talk with dermatologists and cosmetic surgeons on topics ranging from rosacea and acne, to fillers, lasers and facelifts. We hope the topics educate patients, inspire them to ask questions, and maybe even spur them to try a procedure.
To read our content, click here. |  |
| | | | High leptin levels found in psoriasis patients, study shows
Dec 22, 2008
Taipei, Taiwan — Researchers have found that psoriasis patients show high levels of leptin, increasing the chances of other inflammatory diseases associated with this metabolic hormone, Medpage Today reports. | | Blood tests can help diagnose 'flesh-eating bacteria'
Dec 10, 2008
Washington — Researchers have found two simple blood tests can help physicians diagnose "flesh-eating bacteria," according to a study published in The American Journal of Surgery. | | AAD takes position on vitamin D
Dec 8, 2008
Schaumburg, Ill. — The American Academy of Dermatology (AAD)has issued a position statement on vitamin D, recommending that the public obtain an adequate amount of the vitamin through dietary supplements and nutritional sources, MarketWatch reports. | | Indigo naturalis may effectively treat psoriasis
Nov 18, 2008
Hong Kong — Indigo naturalis, a plant used in traditional Chinese medicine, may be effective in treating psoriasis, according to a study. | |
|  More Articles |
| | | | |
FDA approves Allergan’s Latisse
Jan 6, 2009
Irvine, Calif. — The Food and Drug Administration (FDA) has approved Latisse (bimatoprost ophthalmic solution)0.03 percent for the treatment of eyelash hypotrichosis, according to Allergan. | | FDA holds off decision on psoriasis drug
Dec 24, 2008
New York — The Food and Drug Administration (FDA) has held off making a decision on the psoriasis drug ustekinumab (Johnson & Johnson), until they receive certain risk-mitigation information, but will not require new studies, Reuters reports. | | Sol-Gel unveils new research facilities
Dec 16, 2008
Ness Ziona, Israel — Sol-Gel Technologies unveiled a new plant with state-of-the-art facilities for the development of topical dermatology drugs, according to a press release. | | Artes Medical may liquidate after filing for bankruptcy
Dec 10, 2008
San Diego — Artes Medical plans to liquidate, after laying off more than 100 people last month and filing for Chapter 7 bankruptcy this week, SignOnSanDiego.com reports. | |
| | More Articles |
| |
 |  | Competitors to Allergan’s Botox (botulinum toxin A) will soon be entering the aesthetic marketplace, providing dermatologists with an increasing range of products to add to the anti-aging armamentarium. In this month’s Special Report, we look at the changing field of facial rejuvenation therapies, including nutricosmetics, which some experts say could be the next "big boom." We also examine triple combination treatments, which can have a significant impact in slowing the appearance of aging, according to a past president of the American Society for Dermatologic Surgery.
To read our content, click here. |
| 
Dermatology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.